The Cardiac Partners at Cooper and Inspira team recently became the first in the Northeast Region to implant Abbott’s Amplatzer Amulet left atrial appendage (LAA) occluder, a new device recently approved by the FDA to treat patients with atrial fibrillation (AFib) who are also at risk of ischemic stroke.
George E. Mark, MD, FACC, successfully implanted the Amulet device in a male patient in October as part of a multidisciplinary team led by Sajjad A. Read more.

Cooper University Health Care is participating in the U.S. Department of Health and Human Services (HHS) Perinatal Improvement Collaborative, a large-scale, data-driven collaborative of more than 200 leading hospitals caring for diverse populations in all 50 states. The collaborative is overseen by the HHS
By ensuring stroke patients receive the most appropriate treatment according to nationally recognized, research-based guidelines, Cooper University Health Care has received the following awards from the American Heart Association:
Cooper University Health Care’s 